Anixa Biosciences logo

Anixa Biosciences

ANIX | NASDAQ
Chart Builder DCF Calculator
$2.55
-$0.07 (-2.67%)
At close: Nov 16, 2026, 4:00 PM ET
$2.65
+$0.10 (+4.12%)
After-hours: Nov 16, 2026, 7:53 PM ET
-2.67%

Rating

Updated: Nov 16, 2026
31.5
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #756/1021 (Top 74%)

Key Statistics

Market Data

Market Cap $88.65M
1D Range
2.54 2.70
52W Range
2.35 5.22

Valuation (TTM)

PE -8.50
PB 6.13
EV/EBITDA -7.10

Valuation (NTM)

Forward PE N/A
Forward PEG -8.06
Price Target $6.00
Loading financial charts...

Profile

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within...

Sector Healthcare
Industry Biotechnology
Employees 4
IPO Date Oct 7, 1983
Fiscal Year November - October

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
2
Consensus
Buy
Price Target
$6.00
Upside
+135.29%
Buy (2)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.